Trials / Completed
CompletedNCT03158363
A New Model of Acute Febrile Disease
A New Model of Acute Febrile Disease - Combining Endotoxemia, Immobilisation and Fasting in Healthy Young Males.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The investigators want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new model of disease, healthy young adults will be given lipopolysaccharide (LPS) to induce endotoxemia and inflammation/fever and then fast and bedrest for 36 hours. Glucose, fat and protein metabolism will be investigated using clamp technique and tracer methodology together with intracellular signalling pathway activation in muscle and fat biopsies. This new model of disease will later be used in another study to investigate different protein supplement´s effect on muscle waste during acute febrile disease.
Detailed description
The investigators want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new model of disease, healthy young adults will be given lipopolysaccharide (LPS) to induce endotoxemia and inflammation on study day 1 and then fast and bedrest for 36 hours (Study day 2). Glucose, fat and protein metabolism will be investigated using clamp technique and tracer methodology together with intracellular signalling pathway activation in muscle and fat biopsies. This new model of disease will later be used in another study to investigate different protein supplement´s effect on muscle waste during acute febrile disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | LPS, 36 hour immobilization and fast | LPS endotoxin is administered on study day 1 and immobilization and fast continue throughout study day 1 and 2. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-08-31
- Completion
- 2017-08-31
- First posted
- 2017-05-18
- Last updated
- 2019-02-22
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03158363. Inclusion in this directory is not an endorsement.